234 related articles for article (PubMed ID: 34116393)
21. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
Li K; Meyerholz DK; Bartlett JA; McCray PB
mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
[TBL] [Abstract][Full Text] [Related]
22. TMPRSS2 Is Essential for SARS-CoV-2 Beta and Omicron Infection.
Metzdorf K; Jacobsen H; Greweling-Pils MC; Hoffmann M; Lüddecke T; Miller F; Melcher L; Kempf AM; Nehlmeier I; Bruder D; Widera M; Ciesek S; Pöhlmann S; Čičin-Šain L
Viruses; 2023 Jan; 15(2):. PubMed ID: 36851486
[TBL] [Abstract][Full Text] [Related]
23. Serine Protease Inhibitors Restrict Host Susceptibility to SARS-CoV-2 Infections.
Rosendal E; Mihai IS; Becker M; Das D; Frängsmyr L; Persson BD; Rankin GD; Gröning R; Trygg J; Forsell M; Ankarklev J; Blomberg A; Henriksson J; Överby AK; Lenman A
mBio; 2022 Jun; 13(3):e0089222. PubMed ID: 35532162
[TBL] [Abstract][Full Text] [Related]
24. The discovery and development of transmembrane serine protease 2 (TMPRSS2) inhibitors as candidate drugs for the treatment of COVID-19.
Mantzourani C; Vasilakaki S; Gerogianni VE; Kokotos G
Expert Opin Drug Discov; 2022 Mar; 17(3):231-246. PubMed ID: 35072549
[TBL] [Abstract][Full Text] [Related]
25. Structure and activity of human TMPRSS2 protease implicated in SARS-CoV-2 activation.
Fraser BJ; Beldar S; Seitova A; Hutchinson A; Mannar D; Li Y; Kwon D; Tan R; Wilson RP; Leopold K; Subramaniam S; Halabelian L; Arrowsmith CH; Bénard F
Nat Chem Biol; 2022 Sep; 18(9):963-971. PubMed ID: 35676539
[TBL] [Abstract][Full Text] [Related]
26. Blockade of TMPRSS2-mediated priming of SARS-CoV-2 by lactoferricin.
Ohradanova-Repic A; Skrabana R; Gebetsberger L; Tajti G; Baráth P; Ondrovičová G; Praženicová R; Jantova N; Hrasnova P; Stockinger H; Leksa V
Front Immunol; 2022; 13():958581. PubMed ID: 36081512
[TBL] [Abstract][Full Text] [Related]
27. Molecular docking analysis reveals the functional inhibitory effect of Genistein and Quercetin on TMPRSS2: SARS-COV-2 cell entry facilitator spike protein.
Manjunathan R; Periyaswami V; Mitra K; Rosita AS; Pandya M; Selvaraj J; Ravi L; Devarajan N; Doble M
BMC Bioinformatics; 2022 May; 23(1):180. PubMed ID: 35578172
[TBL] [Abstract][Full Text] [Related]
28. Reactive Centre Loop Mutagenesis of SerpinB3 to Target TMPRSS2 and Furin: Inhibition of SARS-CoV-2 Cell Entry and Replication.
Singh S; O'Reilly S; Gewaid H; Bowie AG; Gautier V; Worrall DM
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293378
[TBL] [Abstract][Full Text] [Related]
29. TMPRSS2 Expression and Activity Modulation by Sex-Related Hormones in Lung Calu-3 Cells: Impact on Gender-Specific SARS-CoV-2 Infection.
Treppiedi D; Marra G; Di Muro G; Catalano R; Mangili F; Esposito E; Barbieri AM; Arosio M; Mantovani G; Peverelli E
Front Endocrinol (Lausanne); 2022; 13():862789. PubMed ID: 35712238
[TBL] [Abstract][Full Text] [Related]
30. Repurposing and discovery of transmembrane serine protease 2 (TMPRSS2) inhibitors as prophylactic therapies for new coronavirus disease 2019 (COVID-19).
Yang H; Lin X; Yu Q; Awadasseid A; Zhang W
Pharmazie; 2023 Dec; 78(11):217-224. PubMed ID: 38178286
[TBL] [Abstract][Full Text] [Related]
31. Expression and Clinical Significance of SARS-CoV-2 Human Targets in Neoplastic and Non-Neoplastic Lung Tissues.
Subbarayan K; Ulagappan K; Wickenhauser C; Seliger B
Curr Cancer Drug Targets; 2021 Jul; 21(5):428-442. PubMed ID: 33292131
[TBL] [Abstract][Full Text] [Related]
32. SARS-CoV-2 and SARS-CoV Spike-Mediated Cell-Cell Fusion Differ in Their Requirements for Receptor Expression and Proteolytic Activation.
Hörnich BF; Großkopf AK; Schlagowski S; Tenbusch M; Kleine-Weber H; Neipel F; Stahl-Hennig C; Hahn AS
J Virol; 2021 Apr; 95(9):. PubMed ID: 33608407
[TBL] [Abstract][Full Text] [Related]
33. Expression of ACE2, TMPRSS2, and SARS-CoV-2 nucleocapsid protein in gastrointestinal tissues from COVID-19 patients and association with gastrointestinal symptoms.
Lin L; Zeng F; Mai L; Gao M; Fang Z; Wu B; Huang S; Shi H; He J; Liu Y; Li X; Li Z; Han Y; Yan Z
Am J Med Sci; 2023 Dec; 366(6):430-437. PubMed ID: 37660993
[TBL] [Abstract][Full Text] [Related]
34. Contributions of human ACE2 and TMPRSS2 in determining host-pathogen interaction of COVID-19.
Senapati S; Banerjee P; Bhagavatula S; Kushwaha PP; Kumar S
J Genet; 2021; 100(1):. PubMed ID: 33707363
[TBL] [Abstract][Full Text] [Related]
35. The contrasting role of nasopharyngeal angiotensin converting enzyme 2 (ACE2) transcription in SARS-CoV-2 infection: A cross-sectional study of people tested for COVID-19 in British Columbia, Canada.
Nikiforuk AM; Kuchinski KS; Twa DDW; Lukac CD; Sbihi H; Basham CA; Steidl C; Prystajecky NA; Jassem AN; Krajden M; Patrick DM; Sekirov I
EBioMedicine; 2021 Apr; 66():103316. PubMed ID: 33819740
[TBL] [Abstract][Full Text] [Related]
36. Placental Expression of ACE2 and TMPRSS2 in Maternal Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Are Placental Defenses Mediated by Fetal Sex?
Shook LL; Bordt EA; Meinsohn MC; Pepin D; De Guzman RM; Brigida S; Yockey LJ; James KE; Sullivan MW; Bebell LM; Roberts DJ; Kaimal AJ; Li JZ; Schust D; Gray KJ; Edlow AG
J Infect Dis; 2021 Dec; 224(Suppl 6):S647-S659. PubMed ID: 34293137
[TBL] [Abstract][Full Text] [Related]
37. Initial study on TMPRSS2 p.Val160Met genetic variant in COVID-19 patients.
Wulandari L; Hamidah B; Pakpahan C; Damayanti NS; Kurniati ND; Adiatmaja CO; Wigianita MR; Soedarsono ; Husada D; Tinduh D; Prakoeswa CRS; Endaryanto A; Puspaningsih NNT; Mori Y; Lusida MI; Shimizu K; Oceandy D
Hum Genomics; 2021 May; 15(1):29. PubMed ID: 34001248
[TBL] [Abstract][Full Text] [Related]
38. Expression of ACE2 and TMPRSS2 Proteins in the Upper and Lower Aerodigestive Tracts of Rats: Implications on COVID 19 Infections.
Sato T; Ueha R; Goto T; Yamauchi A; Kondo K; Yamasoba T
Laryngoscope; 2021 Mar; 131(3):E932-E939. PubMed ID: 32940922
[TBL] [Abstract][Full Text] [Related]
39. Smoke and Spike: Benzo[a]pyrene Enhances SARS-CoV-2 Infection by Boosting NR4A2-Induced ACE2 and TMPRSS2 Expression.
Liu W; Zhao Y; Fan J; Shen J; Tang H; Tang W; Wu D; Huang W; Ding Y; Qiao P; Lin J; Li Z; Li Q; Cui Q; Liu Y; Chen Y; Pu R; Han X; Yin J; Tan X; Cao G
Adv Sci (Weinh); 2023 Sep; 10(26):e2300834. PubMed ID: 37428471
[TBL] [Abstract][Full Text] [Related]
40. BC-11 is a covalent TMPRSS2 fragment inhibitor that impedes SARS-CoV-2 host cell entry.
Moumbock AFA; Tran HTT; Lamy E; Günther S
Arch Pharm (Weinheim); 2023 Jan; 356(1):e2200371. PubMed ID: 36316225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
